Sodium Bicarbonate 8.4% w/v is a sterile, non-pyrogenic, hypertonic solution intended for intravenous administration. As a potent systemic alkalinizing agent, it is primarily used in critical care settings to correct metabolic acidosis and manage specific drug toxicities. This solution increases plasma bicarbonate, buffers excess hydrogen ion concentration, and raises blood pH, effectively reversing acidotic states in emergency medical situations.

Key Features & Benefits

• Systemic Alkalinizer: Effectively raises the pH of the blood and urine to treat severe metabolic acidosis.
• Emergency Care Essential: Frequently utilized in Advanced Cardiac Life Support (ACLS) protocols and during cardiopulmonary resuscitation (CPR).
• High Concentration: Formulated at 8.4% w/v, providing $1\text{ mmol/mL}$ each of Sodium ($Na^+$) and Bicarbonate ($HCO_3^-$).
• Pharmaceutical Grade: Manufactured to British Pharmacopoeia (BP) standards, ensuring the highest levels of purity and safety.
• Sterile Packaging: Supplied in a 50ml single-dose glass vial or amber ampoule to maintain integrity and prevent contamination.

Indications (Usage)

• Metabolic Acidosis: Treatment of severe metabolic acidosis associated with cardiac arrest, severe renal disease, or uncontrolled diabetes.
• Toxicity Management: Used in the treatment of certain drug overdoses (e.g., tricyclic antidepressants) to protect the heart.
• Urinary Alkalinization: To increase the excretion of certain drugs and prevent uric acid crystalluria.
• Hyperkalemia: Used as an adjunct therapy to lower high potassium levels in emergency situations.

Directions for Administration

Note: This is a high-alert medication and must only be administered by trained healthcare professionals in a clinical setting.

• Route: For Intravenous (IV) infusion or slow IV injection.
• Dosage: Must be individualized based on the patient's weight, clinical condition, and arterial blood gas (ABG) results.
• Dilution: May be administered undiluted in emergencies or diluted with 5% Dextrose or 0.9% Sodium Chloride for slow infusion.

Safety Information & Contraindications

• Contraindications: Not for use in patients with metabolic or respiratory alkalosis, hypocalcemia, or excessive chloride loss from vomiting.
• Caution: Use with extreme care in patients with congestive heart failure (CHF), severe renal insufficiency, or edema due to high sodium content.
• Monitoring: Continuous monitoring of serum electrolytes and acid-base status is mandatory during administration.
• Storage: Store below 25°C. Do not freeze. Use only if the solution is clear and the seal is intact.